Figure 6From: Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer Platelet count and corresponding corresponding serum CA 125 patient 6. Carboplatin AUC 3/paclitaxel 75 mg/m2 (white bars). Carboplatin AUC 3/paclitaxel 20 mg/m2 (hatched bars). Dose omission (black bars). Serum CA 125.Back to article page